Renin-angiotensin system inhibitors + SGLT2 inhibitors
1 paper
- In silico1
Latest
1 in 12 monthsJournal of the American Society of Nephrology
A Microsimulation of Eligibility for Cardiorenal Combination Treatment and Potential Deaths Averted
Computational studyInterventions